Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All aspirin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchAspirinAspirin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Aspirin and NSAID use and the risk of COVID-19

Drew et al., medRxiv, doi:10.1101/2021.04.28.21256261
May 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Progression 22% Improvement Relative Risk Case -3% Aspirin for COVID-19  Drew et al.  Prophylaxis Is prophylaxis with aspirin beneficial for COVID-19? Retrospective study in multiple countries (March - May 2020) Lower progression with aspirin (not stat. sig., p=0.3) c19early.org Drew et al., medRxiv, May 2021 Favorsaspirin Favorscontrol 0 0.5 1 1.5 2+
Aspirin for COVID-19
24th treatment shown to reduce risk in August 2021
 
*, now with p = 0.000087 from 73 studies, recognized in 3 countries.
Lower risk for mortality and progression.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,300+ studies for 77 treatments. c19early.org
Retrospective 2,736,091 individuals in the U.S., U.K., and Sweden, showing lower risk of hospital/clinic visits with aspirin use.
risk of progression, 22.0% lower, HR 0.78, p = 0.30, adjusted per study, seen in hospital/clinic, comorbidity and symptom adjusted, multivariable.
risk of case, 3.0% higher, HR 1.03, p = 0.80, adjusted per study, comorbidity and symptom adjusted, multivariable.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Drew et al., 2 May 2021, retrospective, multiple countries, preprint, 25 authors, study period 24 March, 2020 - 8 May, 2020. Contact: achan@mgh.harvard.edu.
This PaperAspirinAll
Abstract: medRxiv preprint doi: https://doi.org/10.1101/2021.04.28.21256261; this version posted May 2, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Aspirin and NSAID use and the risk of COVID-19 David A. Drew1,2*, Chuan-Guo Guo1,2,3*, Karla A. Lee4*, Long H. Nguyen1,2,5, Amit D. Joshi1,2, Chun-Han Lo1,2,6, Wenjie Ma1,2, Raaj S. Mehta1,2, Sohee Kwon1,2, Christina M. Astley7,8, Mingyang Song6,9, Richard Davies10, Joan Capdevila10, Mary Ni Lochlainn4, Carole H. Sudre11, Mark S. Graham11, Thomas Varsavsky11, Maria F. Gomez12, Beatrice Kennedy13, Hugo Fitipaldi12, Jonathan Wolf10, Tim D. Spector4, Sebastien Ourselin11, Claire J. Steves4, Andrew T. Chan1,2,8,14,15† Affiliations: 1 Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, U.S.A. 2 Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, U.S.A. 3 Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China 4 Department of Twin Research and Genetic Epidemiology, King’s College London, London, U.K. 5 Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, U.S.A. 6 Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, U.S.A. 7 Division of Endocrinology and Computational Epidemiology Lab, Boston Children's Hospital and Harvard Medical School, Boston, MA, U.S.A. 8 Broad Institute of MIT and Harvard, Cambridge, MA, U.S.A. 9 Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, U.S.A. 10 Zoe Global Ltd., London, U.K. 11 School of Biomedical Engineering & Imaging Sciences, King’s College London, London, U.K. 12 Department of Clinical Sciences, Lund University Diabetes Centre, Lund University, Malmö, Sweden 13 Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden. 14 Department of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health, Boston, MA, U.S.A. 15 Massachusetts Consortium on Pathogen Readiness *Contributed equally to this work †To whom correspondence should be addressed: Andrew T. Chan, MD, MPH, Clinical & Translational Epidemiology Unit, Massachusetts General Hospital, 100 Cambridge St. Boston, MA, 02114. achan@mgh.harvard.edu One Sentence Summary: NSAID use is not associated with COVID-19 risk. NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2021.04.28.21256261; this version posted May 2, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Abstract: Early reports raised concern that use of non-steroidal anti-inflammatory drugs (NSAIDs) may increase risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19). Users of the COVID Symptom Study smartphone application reported use of aspirin and other NSAIDs between March 24 and May 8, 2020. Users were queried daily about symptoms, COVID-19 testing, and healthcare..
{ 'institution': [{'name': 'medRxiv'}], 'indexed': {'date-parts': [[2022, 9, 21]], 'date-time': '2022-09-21T02:28:29Z', 'timestamp': 1663727309988}, 'posted': {'date-parts': [[2021, 5, 2]]}, 'group-title': 'Epidemiology', 'reference-count': 21, 'publisher': 'Cold Spring Harbor Laboratory', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'accepted': {'date-parts': [[2021, 4, 30]]}, 'abstract': '<jats:title>Abstract</jats:title><jats:p>Early reports raised concern that use of ' 'non-steroidal anti-inflammatory drugs (NSAIDs) may increase risk of severe acute respiratory ' 'syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19). Users of the COVID Symptom Study ' 'smartphone application reported use of aspirin and other NSAIDs between March 24 and May 8, ' '2020. Users were queried daily about symptoms, COVID-19 testing, and healthcare seeking ' 'behavior. Cox proportional hazards regression was used to determine the risk of COVID-19 ' 'among according to aspirin or non-aspirin NSAID users. Among 2,736,091 individuals in the ' 'U.S., U.K., and Sweden, we documented 8,966 incident reports of a positive COVID-19 test over ' '60,817,043 person-days of follow-up. Compared to non-users and after stratifying by age, sex, ' 'country, day of study entry, and race/ethnicity, non-aspirin NSAID use was associated with a ' 'modest risk for testing COVID-19 positive (HR 1.23 [1.09, 1.32]), but no significant ' 'association was observed among aspirin users (HR 1.13 [0.92, 1.38]). After adjustment for ' 'lifestyle factors, comorbidities and baseline symptoms, any NSAID use was not associated with ' 'risk (HR 1.02 [0.94, 1.10]). Results were similar for those seeking healthcare for COVID-19 ' 'and were not substantially different according to lifestyle and sociodemographic factors or ' 'after accounting for propensity to receive testing. Our results do not support an association ' 'of NSAID use, including aspirin, with COVID-19 infection. Previous reports of a potential ' 'association may be due to higher rates of comorbidities or use of NSAIDs to treat symptoms ' 'associated with COVID-19.</jats:p><jats:sec><jats:title>One Sentence ' 'Summary</jats:title><jats:p>NSAID use is not associated with COVID-19 ' 'risk.</jats:p></jats:sec>', 'DOI': '10.1101/2021.04.28.21256261', 'type': 'posted-content', 'created': {'date-parts': [[2021, 5, 2]], 'date-time': '2021-05-02T19:15:12Z', 'timestamp': 1619982912000}, 'source': 'Crossref', 'is-referenced-by-count': 1, 'title': 'Aspirin and NSAID use and the risk of COVID-19', 'prefix': '10.1101', 'author': [ {'given': 'David A.', 'family': 'Drew', 'sequence': 'first', 'affiliation': []}, {'given': 'Chuan-Guo', 'family': 'Guo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Karla A.', 'family': 'Lee', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-5436-4219', 'authenticated-orcid': False, 'given': 'Long H.', 'family': 'Nguyen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amit D.', 'family': 'Joshi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chun-Han', 'family': 'Lo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Wenjie', 'family': 'Ma', 'sequence': 'additional', 'affiliation': []}, {'given': 'Raaj S.', 'family': 'Mehta', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sohee', 'family': 'Kwon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christina M.', 'family': 'Astley', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mingyang', 'family': 'Song', 'sequence': 'additional', 'affiliation': []}, {'given': 'Richard', 'family': 'Davies', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joan', 'family': 'Capdevila', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mary Ni', 'family': 'Lochlainn', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-5753-428X', 'authenticated-orcid': False, 'given': 'Carole H.', 'family': 'Sudre', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-4170-1095', 'authenticated-orcid': False, 'given': 'Mark S.', 'family': 'Graham', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomas', 'family': 'Varsavsky', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria F.', 'family': 'Gomez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Beatrice', 'family': 'Kennedy', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hugo', 'family': 'Fitipaldi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jonathan', 'family': 'Wolf', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tim D.', 'family': 'Spector', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-5694-5340', 'authenticated-orcid': False, 'given': 'Sebastien', 'family': 'Ourselin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Claire J.', 'family': 'Steves', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrew T.', 'family': 'Chan', 'sequence': 'additional', 'affiliation': []}], 'member': '246', 'reference': [ { 'key': '2021050406501407000_2021.04.28.21256261v1.1', 'doi-asserted-by': 'publisher', 'DOI': '10.1126/science.abb8034'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.2', 'unstructured': 'U. National Health Service. (NHS UK, nhs.uk, 2020).'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.3', 'unstructured': 'USFDA. (2020), vol. 2020.'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.4', 'unstructured': 'G. Kolata , in The New York Times. (nytimes.com, nytimes.com, 2020), ' 'vol. 2020.'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.5', 'doi-asserted-by': 'crossref', 'first-page': 'e21', 'DOI': '10.1016/S2213-2600(20)30116-8', 'article-title': 'Are patients with hypertension and diabetes mellitus at increased risk ' 'for COVID-19 infection?', 'volume': '8', 'year': '2020', 'journal-title': 'Lancet Respir Med'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.6', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2002032'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.7', 'doi-asserted-by': 'crossref', 'unstructured': 'J. J. Zhang et al., Clinical characteristics of 140 patients infected ' 'with SARS-CoV-2 in Wuhan, China. Allergy, (2020).', 'DOI': '10.1111/all.14238'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.8', 'doi-asserted-by': 'crossref', 'first-page': '475', 'DOI': '10.1016/S2213-2600(20)30079-5', 'article-title': 'Clinical course and outcomes of critically ill patients with SARS-CoV-2 ' 'pneumonia in Wuhan, China: a single-centered, retrospective, ' 'observational study', 'volume': '8', 'year': '2020', 'journal-title': 'Lancet Respir Med'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.9', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S0140-6736(20)30211-7'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.10', 'doi-asserted-by': 'crossref', 'unstructured': 'G. Mancia , F. Rea , M. Ludergnani , G. Apolone , G. Corrao , ' 'Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. ' 'N Engl J Med, (2020).', 'DOI': '10.1056/NEJMoa2006923'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.11', 'unstructured': 'H. R. Reynolds et al., Renin-Angiotensin-Aldosterone System Inhibitors ' 'and Risk of Covid-19. N Engl J Med, (2020).'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.12', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj.m606'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.13', 'doi-asserted-by': 'crossref', 'unstructured': 'C. Wu et al., Risk Factors Associated With Acute Respiratory Distress ' 'Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia ' 'in Wuhan, China. JAMA Intern Med, (2020).', 'DOI': '10.1001/jamainternmed.2020.0994'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.14', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/nrc.2016.4'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.15', 'doi-asserted-by': 'publisher', 'DOI': '10.1126/science.294.5548.1871'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.16', 'doi-asserted-by': 'crossref', 'first-page': '259', 'DOI': '10.1038/nrclinonc.2011.199', 'article-title': 'The role of aspirin in cancer prevention', 'volume': '9', 'year': '2012', 'journal-title': 'Nature Reviews Clinical Oncology'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.17', 'doi-asserted-by': 'publisher', 'DOI': '10.7326/M16-0577'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.18', 'doi-asserted-by': 'crossref', 'first-page': 'e2010478', 'DOI': '10.1001/jamanetworkopen.2020.10478', 'article-title': 'Venous Thrombosis Among Critically Ill Patients With Coronavirus ' 'Disease 2019 (COVID-19)', 'volume': '3', 'year': '2020', 'journal-title': 'JAMA Netw Open'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.19', 'unstructured': 'P. Horby et al., Effect of Dexamethasone in Hospitalized Patients with ' 'COVID-19: Preliminary Report. medRxiv, 2020.2006.2022.20137273 (2020).'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.20', 'doi-asserted-by': 'crossref', 'unstructured': 'D. A. Drew et al., Rapid implementation of mobile technology for ' 'real-time epidemiology of COVID-19. Science, (2020).', 'DOI': '10.1101/2020.04.02.20051334'}, { 'key': '2021050406501407000_2021.04.28.21256261v1.21', 'unstructured': 'W. M. van der Wal , R. B. Geskus , ipw: An R Package for Inverse ' 'Probability Weighting. Journal of Statistical Software; Vol 1, Issue 13 ' '(2011), (2011).'}], 'container-title': [], 'original-title': [], 'link': [ { 'URL': 'https://syndication.highwire.org/content/doi/10.1101/2021.04.28.21256261', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 5, 4]], 'date-time': '2021-05-04T13:50:57Z', 'timestamp': 1620136257000}, 'score': 1, 'resource': {'primary': {'URL': 'http://medrxiv.org/lookup/doi/10.1101/2021.04.28.21256261'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 5, 2]]}, 'references-count': 21, 'URL': 'http://dx.doi.org/10.1101/2021.04.28.21256261', 'relation': {}, 'published': {'date-parts': [[2021, 5, 2]]}, 'subtype': 'preprint'}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit